Oncternal Therapeutics Goes Public After Reverse Merger With GTx

Oncternal Therapeutics has joined the growing ranks of San Diego biotechs to go public, but it didn?t go through an IPO to get there. The San Diego-based company said Monday that it completed a reverse merger with GTx, a Memphis, TN biotech whose market value plummeted last fall after its lead drug candidate failed a [?]